InMode Ltd. (INMD)
NASDAQ: INMD · Real-Time Price · USD
14.33
+0.08 (0.56%)
At close: Apr 16, 2026, 4:00 PM EDT
14.35
+0.02 (0.14%)
After-hours: Apr 16, 2026, 7:15 PM EDT
InMode Revenue
In the year 2025, InMode had annual revenue of $370.50M, down -6.16%. InMode had revenue of $103.85M in the quarter ending December 31, 2025, with 6.13% growth.
Revenue (ttm)
$370.50M
Revenue Growth
-6.16%
P/S Ratio
2.45
Revenue / Employee
$561,356
Employees
660
Market Cap
907.93M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 370.50M | -24.32M | -6.16% |
| Dec 31, 2024 | 394.82M | -97.23M | -19.76% |
| Dec 31, 2023 | 492.05M | 37.78M | 8.32% |
| Dec 31, 2022 | 454.27M | 96.71M | 27.05% |
| Dec 31, 2021 | 357.57M | 151.46M | 73.49% |
| Dec 31, 2020 | 206.11M | 49.75M | 31.81% |
| Dec 31, 2019 | 156.36M | 56.20M | 56.11% |
| Dec 31, 2018 | 100.16M | 46.71M | 87.37% |
| Dec 31, 2017 | 53.46M | 30.37M | 131.59% |
| Dec 31, 2016 | 23.08M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| QuidelOrtho | 2.73B |
| Integra LifeSciences Holdings | 1.64B |
| CONMED | 1.37B |
| Lumexa Imaging Holdings | 1.02B |
| Avanos Medical | 701.20M |
| Bioventus | 568.09M |
| Butterfly Network | 97.61M |
| CeriBell | 89.06M |
INMD News
- 3 days ago - InMode to Report First Quarter 2026 Financial Results and Hold Conference Call on May 6, 2026, Expects Q1 Revenue Between $81.5M-$81.7M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M - PRNewsWire
- 23 days ago - InMode to Present at the 25th Annual Needham Virtual Healthcare Conference - PRNewsWire
- 4 weeks ago - InMode Announces New Share Repurchase Program - PRNewsWire
- 7 weeks ago - InMode to Present at Upcoming Investor Conferences - PRNewsWire
- 7 weeks ago - InMode (INMD) Stock Slips As Board Ends Review - Benzinga
- 7 weeks ago - InMode Announces Conclusion of Independent Transaction Committee Review - PRNewsWire
- 2 months ago - InMode Reports Fourth Quarter and Full Year 2025 Financial Results: Quarterly GAAP Revenue of $103.9 Million and Full Year Revenue of $370.5 Million - PRNewsWire
- 2 months ago - InMode to Participate in the 13th Annual BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference - PRNewsWire